Reading the molecular information behind chronic inflammation?

Coordinators: A. Franke (CAU), P Rosenstiel (CAU)

Modern sequencing technologies allow us to analyze genetic and molecular information on an unprecedented scale. They have become essential for understanding disease mechanisms, identifying biomarkers and distinguishing molecular subtypes of disease.

RTF-VI develops new sequencing technologies and protocols for PMI research and brings them into clinical studies. Depending on the scientific question, this can range from sequencing entire human genomes to analyzing microorganisms and pathogens.

The aim is to make advanced sequencing approaches directly useful for precision medicine. Reliable, high-resolution molecular data can help us identify disease subtypes, discover biomarkers and develop clinical studies that take the individual molecular characteristics of patients into account.